Epidemiology, risk factors and prevention

• Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality

  Xavier Rossello, Caterina Mas-Lladó, Stuart Pocock, Lourdes Vicent, Frans van de Werf, Chee Tang Chin, Nicolas Danchin, Stephen W.L. Lee, Jesús Medina, Yong Huo, Héctor Bueno

  Rev Esp Cardiol. 2022;75:392-400

• Polyphenol intake and cardiovascular risk in the PREDIMED-Plus trial. A comparison of different risk equations

  María Rubín-García, Facundo Vitelli-Storelli, Estefanía Toledo, Sara Castro-Barquero, Anna Tresserra-Rimbau, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Dolores Corella, Álvaro Hernáez, J. Alfredo Martínez, Ángel M. Alonso-Gómez, Julia Wärnberg, Jesús Vioque, Dora Romaguera, José López-Miranda, Ramon Estruch, M. Rosa Bernal-López, José Lapetra, Luís Serra-Majem, Aurora Bueno-Cavanillas, Josep A. Tur, Laura Álvarez-Álvarez, Xavier Pintó, José J. Gaforio, Pilar Matía-Martín, Josep Vidal, Clotilde Vázquez, Lidia Daimiel, Emili Ros, Alfredo Gea, José María Manzanares, Jose V. Sorlí, Helmut Schröder, Itziar Abete, Lucas Tojal-Sierra, Edelys Crespo-Oliva, Andrés González-Botella, Elena Rayó, Antonio García-Rios, Ana María Gómez-Pérez, José Manuel Santos-Lozano, Rafael Bartolomé Resano, Michelle M. Murphy, Carolina Ortega-Azorin, Casimira Medrano, María Ángeles Zulet, ... on behalf of the PREDIMED-PLUS Trial Investigators

  Rev Esp Cardiol. 2022;75:401-11

• The prevalence and incidence rate of overweight and obesity among 2.5 million children and adolescents in Spain

  Jeroen de Bont, Matthew Bennett, Luz M. León-Muñoz, Talita Duarte-Salles

  Rev Esp Cardiol. 2022;75:300-7

• Association between ideal cardiovascular health and telomere length in participants older than 55 years old from the SUN cohort

  Lucia Alonso-Pedrero, Ana Ojeda-Rodríguez, Guillermo Zalba, Cristina Razquin, Miguel Á. Martínez-González, Maira Bes-Rastrollo, Amelia Marti

  Rev Esp Cardiol. 2022;75:308-15

• Prevalence of obesity and associated cardiovascular risk factors in the Spanish population: the ENPE study

  Carmen Pérez-Rodrigo, Gotzone Hervás Bárbara, Marta Gianzo Citores, Javier Aranceta-Bartrina

  Rev Esp Cardiol. 2022;75:232-41

• Smoking-attributable mortality in the autonomous communities of Spain, 2017

  Julia Rey, Mónica Pérez-Ríos, María Isolina Santiago-Pérez, Iñaki Galán, Anna Schiaffino, Leonor Varela-Lema, Gael Naveira, Agustín Montes, María Esther López-Vizcaíno, Alexandra Giraldo-Osorio, Nerea Mourino, Anna Mompart, Alberto Ruano-Ravina

  Rev Esp Cardiol. 2022;75:150-8

• Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism

  Carlos Puig-Jové, Esmeralda Castelblanco, Mireia Falguera, Marta Hernández, Berta Soldevila, María Teresa Julián, Albert Teis, Josep Julve, María Barranco-Altirriba, Josep Franch-Nadal, Manel Puig-Domingo, Emilio Ortega, Núria Amigó, Núria Alonso, Didac Mauricio

  Rev Esp Cardiol. 2022;75:22-30

• Epidemiology and treatment of heart failure in Spain: the HF-PATHWAYS study

  Antoni Sicras-Mainar, Aram Sicras-Navarro, Beatriz Palacios, Luis Varela, Juan F. Delgado

  Rev Esp Cardiol. 2022;75:31-8

• Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

  Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, Michael H. Smolensky, Juan J. Crespo, Alfonso Otero, Manuel Domínguez-Sardiña, Ana Moyá, María T. Ríos, María C. Castiñeira, Pedro A. Callejas, Lorenzo Pousa, Elvira Sineiro, José L. Salgado, Carmen Durán, Juan J. Sánchez, José R. Fernández

  Rev Esp Cardiol. 2021;74:953-61

• Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

  Marcelino Bermúdez-López, Montse Martínez-Alonso, Eva Castro-Boqué, Àngels Betriu, Serafí Cambray, Cristina Farràs, Ferran Barbé, Reinald Pamplona, Albert Lecube, Dídac Mauricio, Francisco Purroy, José Manuel Valdivielso, Elvira Fernández, on behalf of the ILERVAS project collaborators

  Rev Esp Cardiol. 2021;74:1042-53

• Association between ankle-brachial index and cognitive function in participants in the PREDIMED-Plus study: cross-sectional assessment

  Meritxell López, Angel Ríos, Dora Romaguera, Miguel Ángel Martínez-González, Fernando Fernández-Aranda, Jordi Salas-Salvadó, Dolores Corella, Montserrat Fitó, Jesús Vioque, Ángel M. Alonso-Gómez, Edelys Crespo-Oliva, J. Alfredo Martínez, Luís Serra-Majem, Ramón Estruch, Francisco J. Tinahones, José Lapetra, Xavier Pintó, Josep A. Tur, Antonio García-Ríos, Aurora Bueno-Cavanillas, José J. Gaforio, Pilar Matía-Martín, Lidia Daimiel, Rubén Sánchez-Rodríguez, Josep Vidal, Enrique Sanz-Martínez, Emilio Ros, Estefanía Toledo, Laura Barrubés, Rocío Barragán, Rafael de la Torre, Miquel Fiol, Sandra González-Palacios, Carolina Sorto-Sánchez, María Victoria Martín-Ruiz, María Ángeles Zulet, Fátima Díaz-Collado, Rosa Casas, José Carlos Fernández-García, José Manuel Santos-Lozano, Nuria Mallorqui-Bagué, Emma Argelich, Óscar Lecea, Indira Paz-Graniel, José V. Sorlí, Aida Cuenca, ... Aina M. Yáñez

  Rev Esp Cardiol. 2021;74:846-53

• Relationship of healthy vascular aging with lifestyle and metabolic syndrome in the general Spanish population. The EVA study

  Marta Gómez-Sánchez, Leticia Gómez-Sánchez, M. Carmen Patino-Alonso, Rosario Alonso-Domínguez, Natalia Sánchez-Aguadero, José I. Recio-Rodríguez, Jesús González-Sánchez, Luis García-Ortiz, Manuel A. Gómez-Marcos, on behalf of the EVA group

  Rev Esp Cardiol. 2021;74:854-61

• Is the pace of decline in cardiovascular mortality decelerating in Spain?

  Lucía Cayuela, Sara Gómez Enjuto, Blanca Olivares Martínez, Susana Rodríguez-Domínguez, Aurelio Cayuela

  Rev Esp Cardiol. 2021;74:750-6

• Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia

  Itziar Lamiquiz-Moneo, Fernando Civeira, Rocío Mateo-Gallego, Martín Laclaustra, Belén Moreno-Franco, María Teresa Tejedor, Lourdes Palacios, César Martín, Ana Cenarro

  Rev Esp Cardiol. 2021;74:664-73

• Feasibility and results of an intensive cardiac rehabilitation program. Insights from the MxM (Más por Menos) randomized trial

  Almudena Castro-Conde, Manuel Abeytua, Vicente I. Arrarte Esteban, Pedro Caravaca Pérez, Regina Dalmau González-Gallarza, Fernando Garza Benito, Rafael J. Hidalgo Urbano, Joan Torres Marqués, Rafael Vidal-Pérez, Iván J. Nuñez-Gil

  Rev Esp Cardiol. 2021;74:518-25

• Analysis of the dose-response relationship of leisure-time physical activity to cardiovascular disease and all-cause mortality: the REGICOR study

  Albert Clará, Georgina Berenguer, Silvia Pérez-Fernández, Helmut Schröder, Rafel Ramos, María Grau, Irene R. Dégano, Alba Fernández-Sanlés, Jaume Marrugat, Roberto Elosua

  Rev Esp Cardiol. 2021;74:414-20

• Additional value of hybrid PET/MR imaging versus MR or PET performed separately to assess cardiovascular disease

  Patricia Barrio, Beatriz López-Melgar, Ana Fidalgo, M. José Romero-Castro, Andrea Moreno-Arciniegas, Caroline Field, Marjorie Garcerant, Leydimar Anmad Shihadeh, Belén Díaz-Antón, Santiago Ruiz de Aguiar, Lina García Cañamaque, Leticia Fernández-Friera

  Rev Esp Cardiol. 2021;74:303-11

• Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases

  Benito Morentin, M. Paz Suárez-Mier, Ana Monzó, Javier Ballesteros, Pilar Molina, Joaquín Lucena

  Rev Esp Cardiol. 2021;74:225-32

• Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

  Diego López-Otero, Javier López-Pais, Carla Eugenia Cacho-Antonio, Pablo José Antúnez-Muiños, Teba González-Ferrero, Marta Pérez-Poza, Óscar Otero-García, Brais Díaz-Fernández, María Bastos-Fernández, Noelia Bouzas-Cruz, Xoan Carlos Sanmartín-Pena, Alfonso Varela-Román, Manuel Portela-Romero, Luis Valdés-Cuadrado, Antonio Pose-Reino, José Ramón González-Juanatey

  Rev Esp Cardiol. 2021;74:175-82

• Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?

  José R. González-Juanatey, Juan Tamargo, Ferran Torres, Burkhard Weisser, Natalia Oudovenko

  Rev Esp Cardiol. 2021;74:51-8